Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Programs
Chronic Diseases: Research, Control, and Prevention
Posted
9/18/18
Assistance Listing Number
93.068
Overview
Grant Opportunities
1
Grant Awards
71
Federal Agency
Centers for Disease Control and Prevention
Applicant Types
Not listed
Beneficiary Types
Not listed
Additional Information
Not listed
Popular Federal Grant Opportunities
Not listed
Popular Federal Grant Awards
Not listed
Name
Description
Awardee
Assistance Type
Dollars Obligated
(Click to sort descending)
Award Date
(Click to sort descending)
Updated At
(Click to sort descending)
U18DP006289
STUDY TO ASSESS THE INCIDENCE OF TYPE 1 DIABETES IN YOUNG ADULTS
Kaiser Foundation Hospitals
Cooperative Agreement
$2.1m
9/30/16
9/28/21
H75DP002725
SECONDARY STROKE PREVENTION PROGRAM WHITHIN THE STROKE CENTER AT PENN STATE HERSE
Pennsylvania State University
Cooperative Agreement
$100.0k
7/1/10
7/14/10
U1ADP000998
MISSISSIPPI YOUTH TOBACCO SURVEY
Mississippi State University
Block Grant
$98.9k
9/1/07
8/30/07
H75DP001822
PARTNERS ENABLING ACTIVE RURAL LIVING (PEARL) PROJECT: OPPORTUNITIES FOR AND OBST
University System Of New Hampshire
Block Grant
$143.4k
9/1/08
8/26/08
U01DP006093
RAPID ACCESS TO PERINATAL PSYCHIATRIC CARE IN DEPRESSION PROGRAM (RAPPID): AN INNOVATIVE STEPPED-CARE APPROACH FOR OBSTETRICS AND GYNECOLOGY CLINICS
University Of Massachusetts Medical School
Cooperative Agreement
$3.6m
9/30/15
7/1/22
Name
Description
Solicitation Number
Federal Agency
Due Date
(Click to sort descending)
Posted Date
(Click to sort descending)
PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Forecast - This Notice is to inform the eligible United States small business concerns of the reissuance of the Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. When reissued, these FOAs will continue to utilize the R41/R42 and R43/44 grant mechanisms. Modifications to these FOAs will be the inclusion of new and revised research priorities. NIH, CDC, and FDA Institutes and Centers likely to participate in one or more of the FOAs include the following: National Institutes of Health (NIH) National Cancer Institute (NCI) National Eye Institute (NEI) National Heart, Lung, and Blood Institute (NHLBI) National Human Genome Research Institute (NHGRI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute on Drug Abuse (NIDA) National Institute of Environmental Health Sciences (NIEHS) National Institute of General Medical Sciences (NIGMS) National Institute of Mental Health (NIMH) National Institute of Neurological Disorders and Stroke (NINDS) National Institute of Nursing Research (NINR) National Institute on Minority Health and Health Disparities (NIMHD) National Library of Medicine (NLM) National Center for Complementary and Integrative Health (NCCIH) National Center for Advancing Translational Sciences (NCATS) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP) Centers for Disease Control (CDC) Center for Global Health (CGH/CDC) National Center on Birth Defects and Developmental Disabilities (NCBDDD/CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP/CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID/CDC) National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP/CDC) National Center for Immunization and Respiratory Diseases (NCIRD/CDC) National Center for Injury Prevention and Control (NCIPC/CDC) National Institute for Occupational Safety and Health (NIOSH/CDC) National Center for Environmental Health (NCEH/CDC) Center for Preparedness and Response (CPR/CDC) Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER/FDA) Center for Drug Evaluation and Research (CDER/FDA) Center for Food Safety and Applied Nutrition (CFSAN/FDA) Center for Devices and Radiological Health (CDRH/FDA) Center for Veterinary Medicine (CVM/FDA) Office of Critical Path Programs (CPI/FDA) Office of Orphan Products Development (OOPD/FDA) This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects. The FOA is expected to be published in Spring 2020 with an expected application due date in Summer 2020.
PA-21-260
Department of Health and Human Services National Institutes of Health
4/5/22
4/6/21